The global red biotechnology market is expected to grow at a steady rate in the forecast period, 2024-2028. This growth can be attributed to the increasing use of red biotechnology in the biopharmaceutical industry for the production of biologic drugs. Red biotechnology is also used in a variety of other fields, such as diagnostics, gene therapy, clinical trials, and research. This is creating lucrative opportunities for the growth of the global red biotechnology market.
In addition to the increasing use of red biotechnology in the biopharmaceutical industry, other factors that are expected to drive the market growth include:
- The increased demand for red biotechnology for the production of combined vaccines
- The increased use of tissue engineering in the production of artificial bones and skin
- The growing research and advancement in stem cell research to produce new products and methods
These factors are expected to bolster the market growth in the forecast period.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on ” Global Red Biotechnology Market” – https://www.techsciresearch.com/report/red-biotechnology-market/15044.html
The global red biotechnology market is segmented by application into biopharmaceutical production, gene therapy, genetic testing, pharmacogenomics, drug discovery, and others. The biopharmaceutical production segment is expected to dominate the market in the forecast period, owing to the increased research and development in the biopharmaceutical industry for the production and development of drugs and medicines, such as the introduction of CAR-T cell therapy for the treatment of relapsed or refractory (r/r) follicular lymphoma (FL).
By end-user, the market is segmented into pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) and contract research organizations (CROs), research institutes, and others. The pharmaceutical and biotechnology companies segment dominated the market in 2022 and is expected to hold the highest share in the forecast period, due to the increased manufacturing of biologic drugs for the treatment of several chronic diseases.
In addition, the growing prevalence of chronic diseases, rising investment in the healthcare industry and infrastructure, and the growing biopharmaceutical industries are factors that are expected to support market growth and bolster demand for red biotechnology in the forecast period.
Major companies operating in the Global Red Biotechnology Market are:
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Gilead Sciences
- Regeneron Pharmaceuticals, Inc.
- F. Hoffmann-La Roche, Ltd.
- Bruker
- Merck KGaA
- Celgene Corporation
- Amgen, Inc.
- Biogen, Inc.,
Customers can also request for 10% free customization on this report.
“North America region is expected to dominate the global red biotechnology market on account of rising adoption of red biotechnology in production of precision medication and several genetic engineering technologies. Besides, increasing new product approvals and growing mergers and acquisitions among the key players are further expected to support the market growth in the region,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Red Biotechnology Market – Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others), By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery and Others), By End-User (Pharmaceutical and Biotechnology Companies, CMO & CRO, Research Institute and Others), By Region,” has evaluated the future growth potential of Global Red Biotechnology Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Red Biotechnology Market.
Table of Content-
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Red Biotechnology Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)
5.2.2. By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)
5.2.3. By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)
5.2.4. By Company (2022)
5.2.5. By Region
5.3. Product Market Map
6. Asia-Pacific Red Biotechnology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. Product Type
6.2.2. End-User
6.2.3. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Red Biotechnology Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. Product Type
6.3.1.2.2. End-User
6.3.2. India Red Biotechnology Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. Product Type
6.3.2.2.2. End-User
6.3.3. South Korea Red Biotechnology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. Product Type
6.3.3.2.2. End-User
6.3.4. Japan Red Biotechnology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. Product Type
6.3.4.2.2. End-User
6.3.5. Australia Red Biotechnology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. Product Type
6.3.5.2.2. End-User
…………….
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=15044
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]